PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute for Clinical and Molecular Virology, Friedrich-Alexander University of Erlangen-Nürnberg (FAU), 91054 Erlangen, Germany.\', \'Serology and Virology Division, NSW Health Pathology Microbiology, Prince of Wales Hospital, Schools of Women\'s and Children\'s Health, Medicine and Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2031, Australia.\', \'Institute of Organic Chemistry I, FAU, 91058 Erlangen, Germany.\', \'Institute of Virology, Freie Universität Berlin, 14163 Berlin, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 1285810.3390/ijms222312858
?:hasPublicationType
?:journal
  • International journal of molecular sciences
is ?:pmid of
?:pmid
?:pmid
  • 34884662
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.26
?:rankingScore_hIndex
  • 95
is ?:relation_isRelatedTo_publication of
?:title
  • Development of a PROTAC-Based Targeting Strategy Provides a Mechanistically Unique Mode of Anti-Cytomegalovirus Activity.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all